LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.01 | 27.76 | 1179 | 2662 | 0.4428 | 0.7672 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.01 | 27.76 | 144 | 2662 | 0.0541 | 0.2841 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.01 | 27.76 | 1452 | 2662 | 0.5453 | 0.8240 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 37.71 | 27.76 | 55 | 2877 | 0.0191 | 0.1075 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 37.71 | 27.76 | 1211 | 2877 | 0.4208 | 0.7575 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 37.71 | 27.76 | 158 | 2877 | 0.0549 | 0.2966 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 37.71 | 27.76 | 1492 | 2877 | 0.5185 | 0.8131 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 39.41 | 27.76 | 44 | 3105 | 0.0142 | 0.0700 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 39.41 | 27.76 | 1227 | 3105 | 0.3951 | 0.7449 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 39.41 | 27.76 | 179 | 3105 | 0.0576 | 0.3150 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 39.41 | 27.76 | 1548 | 3105 | 0.4985 | 0.8055 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.11 | 27.76 | 51 | 3331 | 0.0153 | 0.0921 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.11 | 27.76 | 1272 | 3331 | 0.3818 | 0.7398 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.11 | 27.76 | 196 | 3331 | 0.0588 | 0.3271 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.11 | 27.76 | 1580 | 3331 | 0.4743 | 0.7953 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.81 | 27.76 | 46 | 3596 | 0.0128 | 0.0746 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.81 | 27.76 | 1326 | 3596 | 0.3687 | 0.7349 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.81 | 27.76 | 208 | 3596 | 0.0578 | 0.3324 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.81 | 27.76 | 1635 | 3596 | 0.4546 | 0.7875 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.52 | 27.76 | 49 | 3884 | 0.0126 | 0.0830 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.52 | 27.76 | 1376 | 3884 | 0.3543 | 0.7291 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.52 | 27.76 | 232 | 3884 | 0.0597 | 0.3470 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.52 | 27.76 | 1664 | 3884 | 0.4284 | 0.7758 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.22 | 27.76 | 58 | 4125 | 0.0141 | 0.1075 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.22 | 27.76 | 1411 | 4125 | 0.3421 | 0.7237 | MN20160318_Q01 | H17 |